Mar 24, 2023
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
Feb 21, 2023
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
Feb 16, 2023
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe